Literature DB >> 29565519

Adverse Events Associated with Immune Checkpoint Blockade.

H Kaan Akturk1,2, Aaron W Michels1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29565519     DOI： 10.1056/NEJMc1801663

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Time to dissect the autoimmune etiology of cancer antibody immunotherapy.

Authors:  Michael Dougan; Massimo Pietropaolo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.

Authors:  Halis Kaan Akturk; Aimon Alkanani; Zhiyuan Zhao; Liping Yu; Aaron W Michels
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

3.  Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis.

Authors:  H K Akturk; D Kahramangil; A Sarwal; L Hoffecker; M H Murad; A W Michels
Journal:  Diabet Med       Date:  2019-07-07       Impact factor: 4.359

4.  Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance.

Authors:  Marcus A Couey; R Bryan Bell; Ashish A Patel; Meghan C Romba; Marka R Crittenden; Brendan D Curti; Walter J Urba; Rom S Leidner
Journal:  J Immunother Cancer       Date:  2019-07-03       Impact factor: 13.751

Review 5.  Immune Checkpoint Inhibitor-Induced Diabetic Ketoacidosis: A Report of Four Cases and Literature Review.

Authors:  A Ram Hong; Jee Hee Yoon; Hee Kyung Kim; Ho-Cheol Kang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-28       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.